Mitchell Daitz is Bluestone Chief Executive Officer and Operating Partner at WindRose Health Investors advising and serving on the Board of several of the firm’s technology-enabled healthcare services businesses, including Bluestone where he has been the Board Chair since 2022.
Throughout his career, Mitchell has distinguished himself as an architect and builder of organizations focused on bringing innovative healthcare services to the marketplace. He was co-founder, CEO and Executive Chairman of Vital Decisions, an organization dedicated to ensuring that the care of individuals experiencing a serious illness aligns with their values and changing preferences throughout every step of their health journey.
Prior to Vital Decisions, he was co-founder and CEO of IntrinsiQ Research, a leading oncology electronic medical record and information company acquired by a private equity firm in 2006 and now a business unit of Amerisource Bergen. He was also the President of Datamonitor, Inc., an international healthcare market advisory firm, and management consultant with Deloitte Consulting.
Education:
Our leadership team upholds our legacy of team-based care built on compassion and trust. With a unique blend of clinical and operational expertise, they empower our teams to help people navigate health journeys with confidence and care.